Researchers at Brigham and Women’s Hospital have engineered cancer cells that track and kill cancer cells. The modified cancer cells have demonstrated anti-cancer efficacy in preclinical studies, destroying both primary and metastatic tumours.
Each year over 8 million people die from cancer worldwide. With increasing life expectancy, the incidence of cancer is rising and it has been estimated that by 2030 over 20 million people will be diagnosed with cancer annually. Already most people today have been affected by cancer either directly or indirectly.